Results
1 -
10 of
11
(Click
here to explore results)
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 5 Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Ramón Cacabelos, Juan Carlos Carril, Oscar Teijido
, 2017
, Pages 75-141
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 14 Ergot Alkaloids. Dorota Jakubczyk, Sarah O'Connor
, 2016
, Pages 379-397
- Drug Discovery for Psychiatric Disorders, CHAPTER 6 Treating the Cognitive Deficits of Schizophrenia. Bruce N. Rogers, David L. Gray
, 2012
, Pages 123-156
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 3 Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows. Nicola Simola
, 2013
, Pages 61-82
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 13 5‐HT1A Receptors as a Therapeutic Target for Parkinson’s Disease. Saki Shimizu, Yukihiro Ohno
, 2013
, Pages 308-326
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 6 D3 Receptor Agonists and Antagonists as Anti‐Parkinsonian Therapeutic Agents. Mark Johnson, Aloke Dutta
, 2013
, Pages 126-148
- Designing Multi-Target Drugs, Chapter 4 Chemoinformatic Approaches to Target Identification. Elisabet Gregori-Puigjané, Michael J. Keiser
, 2012
, Pages 50-65
- Emerging Drugs and Targets for Parkinson's Disease, Subject Index
, 2013
, Pages 390-402
- Chemistry, Biological Activities and Therapeutic Applications of Medicinal Plants in Ayurveda, Chapter 13 Ayurvedic Knowledge Inspired Approach to Modern Drug Discovery. Premalatha Balachandran
, 2023
, Pages 325-373
- The Chemistry of Fungi, Chapter 9 Mycotoxins
, 2008
, Pages 165-176